UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048831
Receipt number R000055642
Scientific Title Development and Reliability and Validity of the convalescent Version of the Falls Self-Efficacy Scale
Date of disclosure of the study information 2022/09/14
Last modified on 2022/09/02 14:09:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development and Reliability and Validity of the convalescent Version of the Falls Self-Efficacy Scale

Acronym

Development and Reliability and Validity of the convalescent Version of the Falls Self-Efficacy Scale

Scientific Title

Development and Reliability and Validity of the convalescent Version of the Falls Self-Efficacy Scale

Scientific Title:Acronym

Development and Reliability and Validity of the convalescent Version of the Falls Self-Efficacy Scale

Region

Japan


Condition

Condition

Inpatients in recovery phase rehabilitation wards

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To develop and test the reliability and validity of a scale measuring fall self-efficacy in patients admitted to a recovery unit.

Basic objectives2

Others

Basic objectives -Others

Reliability, Validity

Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Falls Efficacy Scale International

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(Patients subjects)
a. Inpatients in recovery phase rehabilitation wards.
b. Able to understand the text when responding to the questionnaire.
c. Consented to participate in the study.

(Medical staff subjects)
a. Therapist, Nurse
b. Consent to participate in the study.

Key exclusion criteria

Responding to the scale is burdensome.
Patients who not consent this study.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Saika
Middle name
Last name Aihara

Organization

Tohoku Fukushi University

Division name

Department of Rehabilitation, Faculty of Health Science

Zip code

9818522

Address

1-8-1 Kunimi, Aoba-ku, Sendai City, Miyagi

TEL

022-233-3111

Email

aihara09s@gmail.com


Public contact

Name of contact person

1st name Saika
Middle name
Last name Aihara

Organization

Tohoku Fukushi University

Division name

Department of Rehabilitation, Faculty of Health Science

Zip code

9818522

Address

1-8-1 Kunimi, Aoba-ku, Sendai City, Miyagi

TEL

022-233-3111

Homepage URL


Email

aihara09s@gmail.com


Sponsor or person

Institute

Tohoku Fukushi University

Institute

Department

Personal name



Funding Source

Organization

Tohoku Fukushi University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Tokyo Bay Rehabilitation Hospital
Fujita Health University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics committee of Tokyo Bay Rehabilitation Hospital

Address

4-1-1 Yatsu, Narashino-shi, Chiba

Tel

047-453-9000

Email

shinsakai@wanreha.net


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京湾岸リハビリテーション病院(千葉県)


Other administrative information

Date of disclosure of the study information

2022 Year 09 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 07 Month 21 Day

Date of IRB

2021 Year 07 Month 21 Day

Anticipated trial start date

2022 Year 09 Month 15 Day

Last follow-up date

2024 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A questionnaire will be administered to patients and medical staff admitted to the recovery phase rehabilitation ward. The questionnaire items included the recovery version of the Falls Self-Efficacy Scale, the Falls Efficacy Scale International Version (FES-I), the Falls Risk VAS, the Japanese version of the Morse Falls Scale (MFS), and a face sheet. The results will be used to examine item validity, construct validity, internal consistency, retest reliability, inter-rater reliability, criterion-related validity, and cutoff value calculation validity.


Management information

Registered date

2022 Year 09 Month 02 Day

Last modified on

2022 Year 09 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055642


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name